Gary Charles Robb - 17 May 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Gary Charles
Issuer symbol
CORT
Transactions as of
17 May 2022
Transactions value $
-$684,395
Form type
4
Filing time
19 May 2022, 17:01:31 UTC
Previous filing
18 Mar 2022
Next filing
08 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Sale -$562K -28.7K -40.23% $19.55 42.7K 17 May 2022 Direct
transaction CORT Common Stock Sale -$2.5K -128 -0.3% $19.55 42.6K 18 May 2022 Direct
transaction CORT Common Stock Sale -$120K -6.13K -14.39% $19.57 36.4K 19 May 2022 Direct F1
holding CORT Common Stock 5.81K 17 May 2022 Custodial account for child F2
holding CORT Common Stock 5.81K 17 May 2022 Custodial account for child F2
holding CORT Common Stock 5.81K 17 May 2022 Custodial account for child F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $19.55 to $19.63. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F2 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.